Fox Run Management L.L.C. Has $671,000 Position in Tenet Healthcare Co. (NYSE:THC)

Fox Run Management L.L.C. lifted its stake in shares of Tenet Healthcare Co. (NYSE:THC) by 114.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 5,319 shares of the company’s stock after buying an additional 2,838 shares during the period. Fox Run Management L.L.C.’s holdings in Tenet Healthcare were worth $671,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of THC. True Wealth Design LLC bought a new position in Tenet Healthcare in the 3rd quarter valued at about $38,000. WR Wealth Planners LLC grew its position in Tenet Healthcare by 2,836.4% in the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock valued at $41,000 after acquiring an additional 312 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Tenet Healthcare by 30.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after acquiring an additional 110 shares during the last quarter. Kestra Investment Management LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at approximately $60,000. Finally, Wilmington Savings Fund Society FSB increased its position in Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock worth $66,000 after purchasing an additional 487 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Analyst Ratings Changes

THC has been the subject of several analyst reports. Truist Financial lowered their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company cut Tenet Healthcare from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $205.00 to $150.00 in a report on Monday, November 25th. TD Cowen began coverage on Tenet Healthcare in a report on Wednesday, February 26th. They set a “buy” rating and a $175.00 price objective for the company. Barclays reduced their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research note on Thursday, February 13th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $177.00 target price on shares of Tenet Healthcare in a research report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $163.88.

Tenet Healthcare Trading Up 5.4 %

Shares of THC stock opened at $129.87 on Tuesday. Tenet Healthcare Co. has a 1 year low of $90.03 and a 1 year high of $171.20. The company’s fifty day simple moving average is $132.22 and its two-hundred day simple moving average is $142.92. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The stock has a market capitalization of $12.35 billion, a price-to-earnings ratio of 4.03, a PEG ratio of 1.02 and a beta of 2.06.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. As a group, analysts anticipate that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Insider Buying and Selling at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the sale, the director now owns 27,378 shares in the company, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.93% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.